Skip to main content
Fig. 4 | Particle and Fibre Toxicology

Fig. 4

From: The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo

Fig. 4

a. Percentage of lymphocytes in the BALF after OVA challenge. b. Number of lymphocytes in the BALF after OVA challenge. c. Percentage of lymphocytes in the balf after ova sensitization and challenge. d. Number of lymphocytes in the BALF after OVA sensitization and challenge. See legend to Fig. 3 . In A and B, (*) and (**) P < 0.05 and P < 0.01 vs. PBS alone; (+) P < 0.05 vs. rutile NP. In C and D, (*), (**) and (**) P < 0.05, P < 0.01 and P < 0.01 vs. OVA alone; (+) P < 0.05 vs. OVA + rutile NP; (##) P < 0.05 vs. OVA + anatase NP

Back to article page